As shown in Figures 2 and 3, there is a complex intercellular and intracellular crosstalk mediated by IL-1 signaling in the breast cancer microenvironment, which may contribute to its role in tumor-associated inflammation, immunosuppression during tumor development, metastasis leading to recurrence, and acquired drug resistance. Here, IL1B is linked to breast carcinoma.